| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10011452 | HBV | ENSG00000117601.15 | protein_coding | SERPINC1 | No | No | 462 | P01008 |
| TVIS10011453 | HBV | ENSG00000117601.15 | protein_coding | SERPINC1 | No | No | 462 | P01008 |
| TVIS10021160 | HBV | ENSG00000117601.15 | protein_coding | SERPINC1 | No | No | 462 | P01008 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SERPINC1 |
|---|---|
| DrugBank ID | DB01225 |
| Drug Name | Enoxaparin |
| Target ID | BE0000280 |
| UniProt ID | P01008 |
| Regulation Type | potentiator |
| PubMed IDs | 16207425; 17489664; 19888521 |
| Citations | Peng K, Wang C, Pang BS, Yang YH: [Effects of thrombolysis and anticoagulation on the functions of vascular endothelial cells and coagulation and fibrinolysis in patients with pulmonary thromboembolism]. Zhonghua Jie He He Hu Xi Za Zhi. 2005 Sep;28(9):596-9.@@Lee S, Gibson CM: Enoxaparin in acute coronary syndromes. Expert Rev Cardiovasc Ther. 2007 May;5(3):387-99.@@Bisio A, Vecchietti D, Citterio L, Guerrini M, Raman R, Bertini S, Eisele G, Naggi A, Sasisekharan R, Torri G: Structural features of low-molecular-weight heparins affecting their affinity to antithrombin. Thromb Haemost. 2009 Nov;102(5):865-73. doi: 10.1160/TH09-02-0081. |
| Groups | Approved |
| Direct Classification | |
| SMILES | |
| Pathways | |
| PharmGKB | PA449463 |
| ChEMBL | CHEMBL1201685 |
